All terms in MeSH

Label Id Description
Fritillaria D031410 [A plant genus of the family LILIACEAE. Members of this genus produce imperialine, a steroidal alkaloid which acts at muscarinic receptors. ]
Aldo-Keto Reductase Family 1 Member C2 D08.811.682.047.820.284.875
Brochothrix B03.510.100.120
Rodent Control N06.850.780.200.650.700
Ammotherapy E02.565.020
omega-N-Methylarginine D12.125.095.104.650
Hemosiderosis D006486 [Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the MONONUCLEAR PHAGOCYTE SYSTEM, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin. ]
Hemostasis D006487 [The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. ]
Activator Appliances E06.658.453.578.100
Peripheral Blood Stem Cell Transplantation E04.936.225.687.500.500
Hematopoietic Stem Cell Transplantation E04.936.225.687.500
Hemostasis, Surgical D006488 [Control of bleeding during or after surgery. ]
Hemostatic Techniques D006489 [Techniques for controlling bleeding. ]
Heparin D006493 [A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. ]
Heparin Antagonists D006494 [Coagulant substances inhibiting the anticoagulant action of heparin. ]
Levallorphan D03.132.577.249.413
Cytidine Monophosphate N-Acetylneuraminic Acid D03.383.742.686.246.370.250
Cytidine Monophosphate D03.383.742.686.246.370
Heparin, Low-Molecular-Weight D006495 [Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. ]
Hemangioma C04.557.645.375